Last updated: August 2, 2025
Introduction
Denmark Patent DK2934514 pertains to a pharmaceutical invention, with the patent granted to protect specific compositions or methods associated with a novel drug entity. In the context of global pharmaceutical patent landscapes, understanding the scope and claims of DK2934514 is critical for stakeholders including pharmaceutical companies, generic manufacturers, patent attorneys, and R&D entities seeking to navigate innovation protection, licensing opportunities, or patent challenges within the region and globally.
This review provides an in-depth analysis of the patent's scope, claims, and the broader patent landscape, with focus on its strategic positioning within the medicinal chemistry, pharmacology, and pharmaceutical formulation sectors.
Patent Overview: DK2934514 - Basic Details
Publication Number: DK2934514
Grant Date: Specific date not provided; typically publicly available through the Danish patent office or patent databases.
Applicants and Assignees: Usually assigned to a pharmaceutical innovator or research entity; specific ownership details should be confirmed from the official patent register.
Priority Data: The patent may claim priority from earlier filings, possibly in other jurisdictions, which influences its territorial scope and potential for extension.
Classification: The patent likely falls under IPC classes related to pharmaceuticals, medicinal preparations, and chemistry, specifically in classes such as A61K (medical preparations) and C07D (heterocyclic compounds).
Scope of the Patent
The scope of DK2934514 revolves primarily around the inventive subject matter—either a novel drug compound, a pharmaceutical formulation, a method of treatment, or a combination thereof. Its scope, like most pharmaceutical patents, is defined through claims that delineate the legal boundaries of the monopoly.
Main Aspects of the Patent Scope:
-
Chemical Composition or Compound:
- The patent may claim a specific chemical entity or a pharmaceutical composition containing a novel compound.
- Such claims often include pharmaceutical salts, stereoisomers, derivatives, or formulations tailored for enhanced bioavailability or stability.
-
Method of Treatment:
- Claims may encompass specific therapeutic methods, including indications, dosages, or administration routes.
- These are designed to protect the use of the compound for particular diseases or conditions, e.g., cancers, neurodegenerative disorders, or infectious diseases.
-
Pharmaceutical Formulations:
- Claims might include specific formulations such as sustained-release forms, combination therapies, or delivery systems that enhance efficacy.
-
Manufacturing Processes:
- The patent could extend to novel synthesis methods or purification techniques relevant to the compound’s manufacture.
Analysis of the Patent Claims
Claims Structure & Focus:
-
Independent Claims:
The core claims define the scope of patent protection. In DK2934514, the primary independent claim likely pertains to a novel chemical compound or a specific pharmaceutical composition containing this compound.
-
Dependent Claims:
These narrow the scope, adding features like specific substitutions, stereochemistry, combinations, or administration modes.
Strength & Breadth of Claims:
- Pharmaceutical patents often aim for broad claim coverage to encompass variations; however, their actual enforceability depends on novelty and inventive step.
- The claims must distinguish over prior art, including earlier compounds, formulations, or methods.
Critical Aspects:
-
Novelty:
The claims include a compound or process not previously disclosed in the prior art.
-
Inventive Step:
Claims demonstrate an inventive advance over existing therapies or compositions, such as improved efficacy, reduced side effects, or smoother synthesis routes.
-
Industrial Applicability:
Claims relate to compositions or methods capable of practical implementation, meeting patentability criteria.
Patent Landscape Analysis
Global Patent Context:
- The patent landscape for drugs similar to DK2934514 involves numerous related patents covering chemical classes, mechanisms of action, or therapeutic uses.
- Competitors may have filed patents in jurisdictions such as the US, EP, CN, and others, often with overlapping or adjacent claims.
Key IP Players & Patent Families:
- Likely involved entities include large pharma firms or biotech startups focusing on competitive drug candidates or chemical classes similar to DK2934514.
- Patent families around the core compound suggest strategic patenting to secure broad territorial rights.
Legal Status & Challenges:
- The patent’s enforceability hinges on its prosecution history, grant proceedings, and potential oppositions or challenges.
- Re-examination or validity challenges centered on novelty (such as prior art references) and inventive step are critical aspects to monitor.
Infringement Risks & Opportunities:
- The scope of Claim 1 and subsequent dependent claims influences infringement analysis.
- The patent's claims governing specific chemical structures or methods define the zone for potential licensing or infringement litigation.
Strategic Implications
- For licensees or generic manufacturers, the broadness of claims affects their freedom-to-operate.
- Patent owners may leverage DK2934514 to secure market exclusivity, especially if it covers a novel therapeutic class or a method to treat specific diseases.
Regional & International Coverage:
- Denmark’s patent laws offer robust protection within the jurisdiction, with potential extensions through Patent Cooperation Treaty (PCT) applications or national filings in other countries.
- The patent landscape should be evaluated in the context of global patent families to ascertain the scope of protection and potential for parallel filings.
Conclusion
Denmark Patent DK2934514 exemplifies a targeted approach to patenting novel pharmaceutical compounds and their utility. Its scope, centered around specific chemical entities and methods, aims to establish protective intellectual property rights in the pharmaceutical sector. The claims’ breadth significantly influences its enforceability and commercial value.
Effective leveraging of this patent for strategic positioning requires continuous monitoring of the patent landscape, including potential challenges and patent filings in other jurisdictions. For innovators, viewing DK2934514 within the larger patent ecosystem is essential for maximizing intellectual property assets and avoiding infringement.
Key Takeaways
- Identify the core compound or method protected by DK2934514 and assess its novelty compared to prior art.
- Evaluate the breadth of the claims to determine potential market and research freedom, especially in similar chemical classes or therapeutic areas.
- Monitor global patent activity related to the same compound class or mechanism of action to anticipate challenges or licensing pathways.
- Assess enforceability and validity risks, especially if challenged based on prior art disclosures.
- Leverage the patent strategically in market positioning, especially when seeking exclusivity in Denmark or broader territories through international filings.
FAQs
1. What is the core invention protected by Denmark Patent DK2934514?
The patent protects a novel chemical compound or a specific pharmaceutical composition, and possibly its therapeutic use, though precise details require review of the claims and description.
2. Can DK2934514 be infringed by generic manufacturers?
Yes, if their products or methods fall within the scope of its claims, especially if they produce the patented compound, formulation, or utilize the protected method.
3. Is this patent valid internationally?
DK2934514’s validity is limited to Denmark; however, similar patents could exist in other jurisdictions if filed through PCT or national filings, creating a broader patent family.
4. How does the patent landscape influence drug development?
A dense patent landscape may restrict R&D through blocking patents, but it also offers licensing opportunities. Understanding overlaps helps in designing around existing patents.
5. What strategies can patent holders employ to maximize patent protection?
They can file in multiple jurisdictions, draft broad claims, and pursue patent term extensions or supplementary protection certificates where applicable.
References
- Danish Patent Office. Official database.
- European Patent Office. Patent family and legal status.
- WIPO. Patent cooperation treaty applications and strategics.
- Patent landscape reports for pharmaceutical compounds.
- Legal analyses on patent scope and infringement strategies.
